Capital w/Codeine Interactions
There are 611 drugs known to interact with Capital w/Codeine (acetaminophen/codeine), along with 19 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 133 are major, 465 are moderate, and 13 are minor.
- View all 611 medications that may interact with Capital w/Codeine
- View Capital w/Codeine alcohol/food interactions (2)
- View Capital w/Codeine disease interactions (19)
Most frequently checked interactions
View interaction reports for Capital w / Codeine (acetaminophen / codeine) and the medicines listed below.
- albuterol
- Atrovent (ipratropium)
- bacitracin ophthalmic
- Bactroban (mupirocin topical)
- Coenzyme Q10 (ubiquinone)
- Dulcolax (bisacodyl)
- Famvir (famciclovir)
- hydrocortisone
- melatonin
- Nutropin AQ (somatropin)
- nystatin
- Prilosec (omeprazole)
- Pulmicort Respules (budesonide)
- Tylenol (acetaminophen)
- Zyrtec (cetirizine)
Capital w/Codeine alcohol/food interactions
There are 2 alcohol/food interactions with Capital w / Codeine (acetaminophen / codeine).
Capital w/Codeine disease interactions
There are 19 disease interactions with Capital w / Codeine (acetaminophen / codeine) which include:
- alcoholism
- liver disease
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- PKU
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Report options
More about Capital w / Codeine (acetaminophen / codeine)
- Capital w/Codeine consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: narcotic analgesic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.